Multiple Sclerosis

Physicists have combined nanotechnology, artificial intelligence and molecular biology to design a novel method that can detect Alzheimer’s disease protein markers in blood that are the tell-tale signs of early neurodegeneration.

Scientists have demonstrated in mice that specially designed probiotics can reduce brain inflammation from diseases like multiple sclerosis. The study points to new potential therapies for chronic conditions that may be as simple as popping a pill.

Multiple sclerosis sufferers can experience long periods of remission, but increasingly damaged nerves make relapses more frequent and severe. Scientists now believe, with a little molecular encouragement, those damaged nerves can heal themselves.

Researchers have developed a groundbreaking vaccine that generates immunity against the Epstein-Barr virus, a virus that almost all of us carry and which has been found to be a primary cause of diseases like multiple sclerosis and some cancers.

The blood-brain barrier performs a vital function in keeping out toxins and pathogens, but it can become “leaky.” Now Stanford scientists have identified therapeutic molecules that could help patch it up, to potentially prevent neurological diseases.

A new study has found direct evidence that an over-the-counter antihistamine can repair the protective nerve sheath that’s damaged in people with multiple sclerosis, opening the door to a potential new treatment for the debilitating disease.

Researchers have used microparticle therapy to boost the number of ‘good’ immune cells, reversing nerve cell damage in mice with MS-like symptoms. The finding may to lead to new treatments for multiple sclerosis and other autoimmune diseases.

Autoimmune diseases such as MS and rheumatoid arthritis affect almost four percent of the global population. A new study has now identified a naturally occurring compound that may provide a new way of treating these debilitating diseases.

Investigating ways to head off the chain of events that leads to multiple sclerosis, researchers have found a chemical regulator in mice that causes the inflammatory cascade associated with the disease. They also figured out how to switch it off.

It's often hard to see the forest from the trees but if we zoom out a little it becomes clear 2022 saw some incredible breakthroughs in the world of medical science. All of these stories are landmark moments that are set to shape the future of medicine.

The dysfunction of microglia in the central nervous system is linked to range of diseases, prompting a wide-ranging search for drugs that can alter their activity. New research, however, suggests we might already one such drug at our disposal.

Scientists may have uncovered a new therapy for multiple sclerosis, involving an inflammation-regulating lipid. Tests in mice showed that the lipid reduced symptoms and slowed disease progression, hinting at an underlying mechanism for the condition.